Vault-13

Siren, L.L.C.

New York, NY · CIK 2005245 · 13F filing filed 2026-08-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$4.9bn reported value +36.5% vs Q1 2026
115positions
44.8%in top 10
25 new 31 added 21 reduced 10 sold out vs Q1 2026

Options: 2 call positions ($15.6m notional), 0 put positions (— notional) – listed below, not included above.

This report includes the holdings of 2 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 9,575,013 $526.6m10.69% 10.69% ReducedShares held: Q3 2025 9.3m, Q4 2025 10.8m, Q1 2026 10.8m, Q2 2026 9.6m -1.2m -1,250,000 -11.6%
2 KYMERA THERAPEUTICS INC COM KYMR KYMR 2,935,830 $336.7m6.83% 6.83% ReducedShares held: Q3 2025 3.4m, Q4 2025 3.3m, Q1 2026 3.2m, Q2 2026 2.9m -251.0k -251,000 -7.9%
3 ERASCA INC COM ERAS ERAS 11,397,781 $208.8m4.24% 4.24% AddedShares held: Q3 2025 8.8m, Q4 2025 8.8m, Q1 2026 11.2m, Q2 2026 11.4m +153.5k +153,535 1.4%
4 VERADERMICS INC COMMON STOCK MANE MANE 1,655,374 $203.5m4.13% 4.13% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.5m, Q2 2026 1.7m +150.0k +150,000 10.0%
5 TANGO THERAPEUTICS INC COM TNGX TNGX 6,179,364 $193.2m3.92% 3.92% AddedShares held: Q3 2025 5.9m, Q4 2025 8.2m, Q1 2026 5.7m, Q2 2026 6.2m +522.3k +522,259 9.2%
6 REVOLUTION MEDICINES INC COM RVMD RVMD 900,000 $168.6m3.42% 3.42% ReducedShares held: Q3 2025 1.0m, Q4 2025 1.3m, Q1 2026 1.1m, Q2 2026 900.0k -211.0k -210,980 -19.0%
7 BICARA THERAPEUTICS INC COM BCAX BCAX 5,602,970 $166.4m3.38% 3.38% ReducedShares held: Q3 2025 5.2m, Q4 2025 5.2m, Q1 2026 5.8m, Q2 2026 5.6m -200.0k -200,000 -3.5%
8 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 1,715,476 $139.8m2.84% 2.84% AddedShares held: Q3 2025 2.7m, Q4 2025 1.5m, Q1 2026 1.6m, Q2 2026 1.7m +100.0k +100,000 6.2%
9 BEIGENE LTD SPONSORED ADR ONC ONC 465,000 $132.5m2.69% 2.69% UnchangedShares held: Q3 2025 493.0k, Q4 2025 500.0k, Q1 2026 465.0k, Q2 2026 465.0k
10 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 3,184,629 $129.4m2.63% 2.63% ReducedShares held: Q3 2025 3.9m, Q4 2025 4.5m, Q1 2026 4.4m, Q2 2026 3.2m -1.2m -1,245,634 -28.1%
11 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 1,136,275 $126.2m2.56% 2.56% AddedShares held: Q3 2025 500.0k, Q4 2025 500.0k, Q1 2026 725.5k, Q2 2026 1.1m +410.8k +410,764 56.6%
12 LEXICON PHARMACEUTICALS INC COM NEW LXRX LXRX 44,303,518 $106.3m2.16% 2.16% UnchangedShares held: Q3 2025 38.9m, Q4 2025 38.9m, Q1 2026 44.3m, Q2 2026 44.3m
13 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 1,774,411 $90.1m1.83% 1.83% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 746.2k, Q2 2026 1.8m +1.0m +1,028,185 137.8%
14 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 968,598 $86.0m1.75% 1.75% AddedShares held: Q3 2025 368.6k, Q4 2025 818.6k, Q1 2026 818.6k, Q2 2026 968.6k +150.0k +150,000 18.3%
15 PARABILIS MEDICINES INC COM PBLS PBLS 2,992,259 $81.9m1.66% 1.66% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.0m
16 XENON PHARMACEUTICALS INC COM XENE XENE 1,318,564 $79.6m1.62% 1.62% UnchangedShares held: Q3 2025 812.8k, Q4 2025 812.8k, Q1 2026 1.3m, Q2 2026 1.3m
17 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 7,690,405 $76.8m1.56% 1.56% UnchangedShares held: Q3 2025 7.4m, Q4 2025 7.7m, Q1 2026 7.7m, Q2 2026 7.7m
18 ABIVAX SA SPONSORED ADS ABVX ABVX 576,000 $76.8m1.56% 1.56% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 576.0k
19 HEMAB THERAPEUTICS HLDGS INC COM SHS COAG COAG 2,086,834 $76.6m1.56% 1.56% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.1m
20 ARCUS BIOSCIENCES INC COM RCUS RCUS 2,420,430 $74.6m1.51% 1.51% ReducedShares held: Q3 2025 2.9m, Q4 2025 3.0m, Q1 2026 3.0m, Q2 2026 2.4m -586.6k -586,647 -19.5%
21 COGENT BIOSCIENCES INC COM COGT COGT 1,859,279 $72.0m1.46% 1.46% AddedShares held: Q3 2025 1.7m, Q4 2025 1.6m, Q1 2026 1.7m, Q2 2026 1.9m +150.0k +150,000 8.8%
22 RELAY THERAPEUTICS INC COM RLAY RLAY 3,650,000 $68.3m1.39% 1.39% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.6m
23 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 9,846,579 $67.1m1.36% 1.36% AddedShares held: Q3 2025 11.0m, Q4 2025 10.1m, Q1 2026 8.8m, Q2 2026 9.8m +1.0m +1,016,666 11.5%
24 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 1,419,493 $66.8m1.36% 1.36% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 919.5k, Q2 2026 1.4m +500.0k +500,000 54.4%
25 STOKE THERAPEUTICS INC COM STOK STOK 1,995,347 $65.3m1.33% 1.33% UnchangedShares held: Q3 2025 2.2m, Q4 2025 2.2m, Q1 2026 2.0m, Q2 2026 2.0m
26 DISC MEDICINE INC COM IRON IRON 888,401 $65.0m1.32% 1.32% ReducedShares held: Q3 2025 913.4k, Q4 2025 988.4k, Q1 2026 988.4k, Q2 2026 888.4k -100.0k -100,000 -10.1%
27 CYTOKINETICS INC COM NEW CYTK CYTK 758,952 $64.7m1.31% 1.31% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 614.0k, Q2 2026 759.0k +145.0k +145,000 23.6%
28 SEPTERNA INC COM SEPN SEPN 1,900,000 $63.6m1.29% 1.29% ReducedShares held: Q3 2025 2.2m, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 1.9m -100.0k -100,000 -5.0%
29 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 4,856,949 $60.8m1.23% 1.23% AddedShares held: Q3 2025 0, Q4 2025 3.3m, Q1 2026 4.8m, Q2 2026 4.9m +100.0k +100,000 2.1%
30 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,420,788 $53.2m1.08% 1.08% ReducedShares held: Q3 2025 1.7m, Q4 2025 1.5m, Q1 2026 1.9m, Q2 2026 1.4m -482.8k -482,848 -25.4%
31 KAILERA THERAPEUTICS INC COMMON STOCK KLRA KLRA 2,214,286 $48.8m0.99% 0.99% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.2m
32 DYNE THERAPEUTICS INC COM DYN DYN 2,129,125 $47.3m0.96% 0.96% ReducedShares held: Q3 2025 4.7m, Q4 2025 3.5m, Q1 2026 2.2m, Q2 2026 2.1m -100.0k -100,000 -4.5%
33 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 872,967 $46.9m0.95% 0.95% ReducedShares held: Q3 2025 1.0m, Q4 2025 1.1m, Q1 2026 1.3m, Q2 2026 873.0k -455.7k -455,731 -34.3%
34 TABOOLA.COM LTD ORD SHS TBLA TBLA 8,423,410 $42.1m0.86% 0.86% ReducedShares held: Q3 2025 10.0m, Q4 2025 10.0m, Q1 2026 10.0m, Q2 2026 8.4m -1.5m -1,546,085 -15.5%
35 PALVELLA THERAPEUTICS INC NE COM PVLA PVLA 257,485 $39.3m0.80% 0.80% UnchangedShares held: Q3 2025 0, Q4 2025 75.0k, Q1 2026 257.5k, Q2 2026 257.5k
36 SILENCE THERAPEUTICS PLC ADS SLN SLN 3,311,438 $36.4m0.74% 0.74% AddedShares held: Q3 2025 2.9m, Q4 2025 2.9m, Q1 2026 2.9m, Q2 2026 3.3m +400.0k +400,000 13.7%
37 DENALI THERAPEUTICS INC COM DNLI DNLI 1,396,513 $35.9m0.73% 0.73% UnchangedShares held: Q3 2025 821.5k, Q4 2025 1.4m, Q1 2026 1.4m, Q2 2026 1.4m
38 REMITLY GLOBAL INC COM RELY RELY 1,543,271 $34.6m0.70% 0.70% UnchangedShares held: Q3 2025 1.6m, Q4 2025 1.6m, Q1 2026 1.5m, Q2 2026 1.5m
39 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,893,410 $34.5m0.70% 0.70% AddedShares held: Q3 2025 1.2m, Q4 2025 1.2m, Q1 2026 1.2m, Q2 2026 1.9m +700.0k +700,000 58.7%
40 CAPITAL ONE FINL CORP COM COF COF 171,615 $34.4m0.70% 0.70% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 171.6k
41 TREVI THERAPEUTICS INC COM TRVI TRVI 1,786,867 $33.3m0.68% 0.68% UnchangedShares held: Q3 2025 2.5m, Q4 2025 2.3m, Q1 2026 1.8m, Q2 2026 1.8m
42 ORIC PHARMACEUTICALS INC COM ORIC ORIC 2,998,192 $32.5m0.66% 0.66% UnchangedShares held: Q3 2025 1.0m, Q4 2025 1.0m, Q1 2026 3.0m, Q2 2026 3.0m
43 ALPHABET INC CAP STK CL A GOOGL GOOGL 90,000 $32.2m0.65% 0.65% AddedShares held: Q3 2025 21.2k, Q4 2025 20.7k, Q1 2026 65.7k, Q2 2026 90.0k +24.3k +24,297 37.0%
44 DBV TECHNOLOGIES S A SPONSORED ADS DBVT DBVT 1,857,362 $30.5m0.62% 0.62% UnchangedShares held: Q3 2025 0, Q4 2025 1.9m, Q1 2026 1.9m, Q2 2026 1.9m
45 ABSCI CORPORATION COM ABSI ABSI 2,474,764 $28.7m0.58% 0.58% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.8m, Q2 2026 2.5m +674.8k +674,764 37.5%
46 SIONNA THERAPEUTICS INC COM SION SION 610,515 $26.9m0.55% 0.55% AddedShares held: Q3 2025 325.0k, Q4 2025 300.0k, Q1 2026 300.0k, Q2 2026 610.5k +310.5k +310,515 103.5%
47 RAPPORT THERAPEUTICS INC COM RAPP RAPP 641,469 $26.7m0.54% 0.54% UnchangedShares held: Q3 2025 1.1m, Q4 2025 708.5k, Q1 2026 641.5k, Q2 2026 641.5k
48 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 1,480,586 $26.6m0.54% 0.54% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.2m, Q2 2026 1.5m +250.6k +250,586 20.4%
49 ANNEXON INC COM ANNX ANNX 4,458,646 $25.5m0.52% 0.52% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.0m, Q2 2026 4.5m +500.0k +500,000 12.6%
50 MONOPAR THERAPEUTICS INC COM NEW MNPR MNPR 270,118 $25.0m0.51% 0.51% UnchangedShares held: Q3 2025 0, Q4 2025 212.3k, Q1 2026 270.1k, Q2 2026 270.1k
51 ORUKA THERAPEUTICS INC COM ORKA ORKA 250,000 $23.8m0.48% 0.48% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
52 SEAPORT THERAPEUTICS INC COMMON STOCK SPTX SPTX 1,095,316 $23.8m0.48% 0.48% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.1m
53 DAMORA THERAPEUTICS INC COM NEW COM NEW 900,000 $23.4m0.48% 0.48% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 900.0k, Q2 2026 900.0k
54 TYRA BIOSCIENCES INC COM TYRA TYRA 725,000 $23.2m0.47% 0.47% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 725.0k
55 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 3,734,866 $22.0m0.45% 0.45% UnchangedShares held: Q3 2025 0, Q4 2025 1.3m, Q1 2026 3.7m, Q2 2026 3.7m
56 TAIWAN SEMICONDUCTOR MFG LTD SPONSORED ADS TSM TSM 44,700 $21.3m0.43% 0.43% AddedShares held: Q3 2025 28.2k, Q4 2025 27.7k, Q1 2026 42.2k, Q2 2026 44.7k +2.5k +2,500 5.9%
57 NVIDIA CORPORATION COM NVDA NVDA 95,000 $19.0m0.39% 0.39% AddedShares held: Q3 2025 37.5k, Q4 2025 37.5k, Q1 2026 89.1k, Q2 2026 95.0k +5.9k +5,915 6.6%
58 REZOLUTE INC COM NEW RZLT RZLT 3,328,287 $17.3m0.35% 0.35% UnchangedShares held: Q3 2025 4.9m, Q4 2025 0, Q1 2026 3.3m, Q2 2026 3.3m
59 MAPLIGHT THERAPEUTICS INC COM MPLT MPLT 450,000 $16.1m0.33% 0.33% UnchangedShares held: Q3 2025 0, Q4 2025 450.0k, Q1 2026 450.0k, Q2 2026 450.0k
60 NEUMORA THERAPEUTICS INC. COM NMRA NMRA 8,497,822 $14.4m0.29% 0.29% UnchangedShares held: Q3 2025 4.4m, Q4 2025 6.3m, Q1 2026 8.5m, Q2 2026 8.5m
61 NEBIUS GROUP N.V. SHS CLASS A NBIS NBIS 52,000 $14.4m0.29% 0.29% ReducedShares held: Q3 2025 72.6k, Q4 2025 76.2k, Q1 2026 113.6k, Q2 2026 52.0k -61.6k -61,614 -54.2%
62 MICROSOFT CORP COM MSFT MSFT 37,500 $14.0m0.28% 0.28% ReducedShares held: Q3 2025 17.1k, Q4 2025 15.0k, Q1 2026 41.4k, Q2 2026 37.5k -3.9k -3,880 -9.4%
63 CYTOMX THERAPEUTICS INC COM CTMX CTMX 3,457,711 $13.0m0.26% 0.26% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 3.5m, Q2 2026 3.5m
64 GENERATE BIOMEDICINES INC COM SHS GENB GENB 736,104 $12.4m0.25% 0.25% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 736.1k, Q2 2026 736.1k
65 INHIBIKASE THERAPEUTICS INC COM NEW IKT IKT 5,850,000 $11.9m0.24% 0.24% UnchangedShares held: Q3 2025 0, Q4 2025 5.8m, Q1 2026 5.8m, Q2 2026 5.8m
66 ADAGENE INC ADS ADAG ADAG 2,666,666 $11.2m0.23% 0.23% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.7m
67 ENGENE THERAPEUTICS INC COM ENGN ENGN 6,256,662 $10.8m0.22% 0.22% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 6.3m
68 AADI BIOSCIENCE INC COM WHWK WHWK 2,337,102 $10.7m0.22% 0.22% AddedShares held: Q3 2025 2.1m, Q4 2025 2.1m, Q1 2026 2.1m, Q2 2026 2.3m +255.1k +255,102 12.2%
69 DATADOG INC CL A COM DDOG DDOG 40,000 $10.4m0.21% 0.21% ReducedShares held: Q3 2025 32.9k, Q4 2025 36.4k, Q1 2026 54.3k, Q2 2026 40.0k -14.3k -14,300 -26.3%
70 SERVICENOW INC COM NOW NOW 100,000 $9.9m0.20% 0.20% AddedShares held: Q3 2025 35.6k, Q4 2025 35.6k, Q1 2026 87.1k, Q2 2026 100.0k +12.9k +12,910 14.8%
71 BROADCOM INC COM AVGO AVGO 25,000 $9.4m0.19% 0.19% AddedShares held: Q3 2025 0, Q4 2025 7.0k, Q1 2026 15.0k, Q2 2026 25.0k +10.0k +10,000 66.7%
72 IONQ INC COM IONQ IONQ 170,000 $9.1m0.18% 0.18% UnchangedShares held: Q3 2025 170.0k, Q4 2025 170.0k, Q1 2026 170.0k, Q2 2026 170.0k
73 JFROG LTD ORD SHS FROG FROG 95,500 $8.7m0.18% 0.18% ReducedShares held: Q3 2025 107.1k, Q4 2025 93.6k, Q1 2026 128.8k, Q2 2026 95.5k -33.3k -33,316 -25.9%
74 OCULIS HOLDING AG ORDINARY SHARES OCS OCS 625,000 $8.7m0.18% 0.18% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 625.0k
75 IREN LIMITED ORDINARY SHARES IREN IREN 175,000 $8.0m0.16% 0.16% AddedShares held: Q3 2025 20.0k, Q4 2025 43.1k, Q1 2026 43.1k, Q2 2026 175.0k +131.9k +131,900 306.0%
76 AMAZON COM INC COM AMZN AMZN 32,500 $7.7m0.16% 0.16% ReducedShares held: Q3 2025 58.5k, Q4 2025 51.5k, Q1 2026 46.6k, Q2 2026 32.5k -14.1k -14,141 -30.3%
77 CROWDSTRIKE HLDGS INC CL A CRWD CRWD 10,000 $7.6m0.15% 0.15% ReducedShares held: Q3 2025 18.5k, Q4 2025 16.5k, Q1 2026 23.1k, Q2 2026 10.0k -13.1k -13,070 -56.6%
78 DESIGN THERAPEUTICS INC COM DSGN DSGN 523,212 $7.6m0.15% 0.15% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 523.2k
79 PDD HOLDINGS INC SPONSORED ADS PDD PDD 95,000 $7.2m0.15% 0.15% AddedShares held: Q3 2025 43.4k, Q4 2025 63.4k, Q1 2026 83.4k, Q2 2026 95.0k +11.6k +11,599 13.9%
80 SATELLOS BIOSCIENCE INC COM MSLE MSLE 892,074 $6.9m0.14% 0.14% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 892.1k, Q2 2026 892.1k
81 DYNATRACE INC COM NEW DT DT 155,000 $6.8m0.14% 0.14% AddedShares held: Q3 2025 100.2k, Q4 2025 115.2k, Q1 2026 150.0k, Q2 2026 155.0k +5.0k +5,000 3.3%
82 TENAX THERAPEUTICS INC COM NEW TENX TENX 427,141 $6.2m0.13% 0.13% UnchangedShares held: Q3 2025 352.4k, Q4 2025 427.1k, Q1 2026 427.1k, Q2 2026 427.1k
83 VTV THERAPEUTICS INC CL A NEW VTVT VTVT 163,000 $6.1m0.12% 0.12% UnchangedShares held: Q3 2025 163.0k, Q4 2025 163.0k, Q1 2026 163.0k, Q2 2026 163.0k
84 ELOXX PHARMACEUTICALS INC COM NEW ELOX ELOX 400,000 $5.6m0.11% 0.11% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 400.0k
85 AGOMAB THERAPEUTICS NV SPONSORED ADS AGMB AGMB 411,250 $5.3m0.11% 0.11% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 411.2k, Q2 2026 411.2k
86 ALIBABA GROUP HLDG LTD SPONSORED ADS BABA BABA 50,000 $4.8m0.10% 0.10% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 50.0k
87 KORRO BIO INC COM KRRO KRRO 347,718 $4.6m0.09% 0.09% UnchangedShares held: Q3 2025 418.8k, Q4 2025 347.7k, Q1 2026 347.7k, Q2 2026 347.7k
88 CELLEBRITE DI LTD ORDINARY SHARES CLBT CLBT 311,544 $4.5m0.09% 0.09% UnchangedShares held: Q3 2025 90.0k, Q4 2025 150.0k, Q1 2026 311.5k, Q2 2026 311.5k
89 INVIVYD INC COM IVVD IVVD 5,000,000 $4.4m0.09% 0.09% AddedShares held: Q3 2025 0, Q4 2025 4.0m, Q1 2026 4.0m, Q2 2026 5.0m +1.0m +1,000,000 25.0%
90 OUSTER INC COM NEW OUST OUST 67,500 $4.2m0.09% 0.09% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 67.5k
91 PALISADE BIO INC COM PALI PALI 2,000,000 $4.2m0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.0m
92 AEVA TECHNOLOGIES INC COM NEW AEVA AEVA 145,459 $4.2m0.08% 0.08% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 110.0k, Q2 2026 145.5k +35.5k +35,459 32.2%
93 SEER INC COM CL A SEER SEER 2,458,673 $4.1m0.08% 0.08% UnchangedShares held: Q3 2025 4.0m, Q4 2025 4.0m, Q1 2026 2.5m, Q2 2026 2.5m
94 I MAB SPONSORED ADS NBP NBP 2,004,739 $3.9m0.08% 0.08% ReducedShares held: Q3 2025 1.2m, Q4 2025 3.0m, Q1 2026 3.0m, Q2 2026 2.0m -995.3k -995,261 -33.2%
95 GITLAB INC CLASS A COM GTLB GTLB 125,000 $3.8m0.08% 0.08% AddedShares held: Q3 2025 64.0k, Q4 2025 99.0k, Q1 2026 100.0k, Q2 2026 125.0k +25.0k +25,000 25.0%
96 ODYSSEY THERAPEUTICS INC COMMON STOCK ODTX ODTX 200,000 $3.7m0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 200.0k
97 FOGHORN THERAPEUTICS INC COM FHTX FHTX 720,720 $3.5m0.07% 0.07% UnchangedShares held: Q3 2025 720.7k, Q4 2025 720.7k, Q1 2026 720.7k, Q2 2026 720.7k
98 AGENUS INC COM NEW AGEN AGEN 1,064,250 $3.3m0.07% 0.07% UnchangedShares held: Q3 2025 1.1m, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.1m
99 MONDAY COM LTD SHS MNDY MNDY 42,500 $3.1m0.06% 0.06% AddedShares held: Q3 2025 7.0k, Q4 2025 17.0k, Q1 2026 25.0k, Q2 2026 42.5k +17.5k +17,500 70.0%
100 ZOETIS INC CL A ZTS ZTS 35,000 $2.5m0.05% 0.05% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 35.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
CENTESSA PHARMACEUTICALS PLC 1,053,464 $41.8m1.1m shares
ENGENE HOLDINGS INC 5,253,159 $35.8m5.3m shares
FULCRUM THERAPEUTICS INC FULC FULC 2,350,000 $18.0m2.4m shares
WAVE LIFE SCIENCES LTD 96663EUR 96663EUR 2,450,000 $17.8m2.5m shares
UNIQURE NV QURE QURE 1,000,000 $16.4m1.0m shares
BICYCLE THERAPEUTICS PLC BCYC BCYC 1,560,882 $7.2m1.6m shares
FORGENT POWER SOLUTIONS INC FPS FPS 100,000 $2.9m100.0k shares
MICRON TECHNOLOGY INC MU MU 6,000 $2.0m6.0k shares
AMER SPORTS INC AS AS 50,000 $1.6m50.0k shares
PRIMO BRANDS CORPORATION PRMB PRMB 50,000 $941.5k50.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
MICROSOFT CORP MSFT · Call MSFTCall 24,000 $9.0m24.0k shares New
APPLE INC AAPL · Call AAPLCall 23,000 $6.7m23.0k shares New